Certara's scientific consultants support strategic drug development decisions and submission-ready analyses.
Drug development and commercialization is difficult. Your choice of a model-based drug development partner to help you predict, design and analyze your preclinical and clinical studies shouldn’t be.
We conduct our work based on the following principles:
Uncompromising scientific integrity
From Discovery through Development
Supporting Eleven Recent Drug Approvals with Model Based Drug Development
Certara’s Pharsight Consulting Services is applying quantative models to decision making, helping accelerate FDA approvals